SCHEMBL6680100

SCHEMBL6680100

CC(CC(=O)Oc1ccc(S(=O)(=O)O)cc1)CC(C)(C)C.[NaH]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 4/20 0.45
MMP1 P03956 1/20 0.45
MMP3 P08254 1/20 0.45
KMT2A Q03164 2/20 0.42
ELANE P08246 5/20 0.40
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
MMP9 P14780 2/20 0.34
MMP14 P50281 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 1/20 0.34
HSD17B10 Q99714 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ESR1 P03372 1/20 0.33
HIF1A Q16665 1/20 0.33
PRTN3 P24158 1/20 0.32
PRSS1 P07477 1/20 0.32
ACR P10323 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167977 0.99 MMP2 (0.46) MMP2MMP1MMP3KMT2AELANE
SCHEMBL20942807 0.86 MMP2 (0.45) MMP2MMP1MMP3KMT2AELANE
SCHEMBL3190285 0.86 MMP2 (0.45) MMP2MMP1MMP3KMT2AELANE
SCHEMBL60869 0.81 L3MBTL1 (0.43) MMP2MMP1MMP3KMT2AELANE
SCHEMBL6566817 0.80 L3MBTL1 (0.44) KMT2AELANEMAPTALDH1A1LMNA
SCHEMBL3191723 0.79 KMT2A (0.46) KMT2AELANEMAPTPKMHTT
SCHEMBL5466190 0.78 BCL9 (0.56) KMT2AMAPTPKMALDH1A1HTT
SCHEMBL28371379 0.78 CYP1A2 (0.39) MMP2MMP1MMP3KMT2AELANE
SCHEMBL10636417 0.77 ELANE (0.39) MMP2MMP1MMP3KMT2AELANE
SCHEMBL10497327 0.77 MMP1 (0.40) MMP2MMP1MMP3KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1095 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647947-B2 Detergent composition NOVOZYMES A/S (DK) 2020-05-12 US claimed
US-12630812-B2 Subtilase variants and polynucleotides encoding same NOVOZYMES A/S (DK) 2026-05-19 US disclosed
US-20260132388-A1 LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS NOVOZYMES A/S (DK) 2026-05-14 US disclosed
EP-4739760-A1 WASHING METHOD FOR REMOVING PROTEINACEOUS STAINS Novozymes A/S (DK) 2026-05-13 EP disclosed
EP-3607038-B1 CLEANING COMPOSITIONS AND USES THEREOF NOVOZYMES AS (DK) 2026-05-06 EP disclosed
EP-3708660-B1 POLYPEPTIDES NOVOZYMES AS (DK) 2026-04-29 EP disclosed
US-12606810-B2 Subtilase variants and compositions comprising same NOVOZYMES A/S (DK) 2026-04-21 US disclosed
EP-3704220-B1 METHODS FOR CLEANING MEDICAL DEVICES NOVOZYMES AS (DK) 2026-04-15 EP disclosed
EP-4717756-A2 LIPASE VARIANTS AND DETERGENT COMPOSITIONS Novozymes A/S (DK) 2026-04-01 EP disclosed
US-20260078359-A1 POLYPEPTIDES NOVOZYMES A/S (DK) 2026-03-19 US disclosed
EP-0535942-B2 Fabric treatment compositions comprising perfume particles UNILEVER PLC (GB) 2004-11-24 EP disclosed
EP-0826026-B1 PARTICLES CONTAINING PERFUME UNILEVER PLC (GB) 2001-05-09 EP disclosed
EP-0535942-B1 Fabric treatment compositions comprising perfume particles UNILEVER PLC (GB) 1999-02-03 EP disclosed
EP-0826026-A1 PARTICLES CONTAINING PERFUME UNILEVER PLC (GB) 1998-03-04 EP disclosed
WO-1996021719-A1 PARTICLES CONTAINING PERFUME UNILEVER PLC (GB) 1996-07-18 WO disclosed
US-5336665-A Hydrophobic porous carrier for use in detergents; controls intensity of perfume delivered to fabric LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) 1994-08-09 US disclosed
EP-0536942-A2 Perfume particles UNILEVER PLC (GB) 1993-04-14 EP disclosed
EP-0535942-A2 Perfume particles UNILEVER PLC (GB) 1993-04-07 EP disclosed
US-4883612-A Preparation of para-acyloxybenzene sulfonates RHONE-POULENC CHIMIE DE BASE (FR) 1989-11-28 US disclosed
US-4588532-A Preparation of para-acyloxybenzene sulfonates RHONE-POULENC CHIMIE DE BASE (FR) 1986-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132388-A1 LIPASE VARIANTS AND MICROCAPSULE COMPOSITIONS COMPRISING SUCH LIPASE VARIANTS LIPE, LPL, PNLIP MMP2 262/4885MMP1 237/4885MMP3 455/4885
US-20260078359-A1 POLYPEPTIDES IDUA, IDE, AGL MMP2 147/4885MMP1 182/4885MMP3 937/4885
US-12606810-B2 Subtilase variants and compositions comprising same PRSS1, CTRL, TMPRSS11D MMP2 158/4885MMP1 250/4885MMP3 94/4885
US-12630812-B2 Subtilase variants and polynucleotides encoding same RNASE1, PEPD, DPP9 MMP2 107/4885MMP1 270/4885MMP3 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.